Table 5.
Analysis of risk factors for graft survival in patients with IgAN in biopsy of native kidney.
| P value | HR | 95% CI for HR | ||
|---|---|---|---|---|
| Lower | Upper | |||
| EU till 1 year after Tx | 0.000 | 4.638 | 2.562 | 8.394 |
| PU till 1 year after Tx | 0.000 | 7.236 | 3.315 | 15.797 |
| reIgAN | 0.000 | 3.305 | 1.937 | 5.640 |
| ABMR | 0.001 | 3.242 | 1.653 | 6.358 |
| Age—recipient | 0.001 | 0.961 | 0.939 | 0.984 |
| Age—RB | 0.002 | 0.962 | 0.939 | 0.986 |
| Retransplantation | 0.060 | 2.167 | 0.967 | 4.855 |
| Recurrence to 2y after Tx | 0.106 | 2.214 | 0.844 | 5.806 |
| Gender—donor, male | 0.112 | 0.606 | 0.326 | 1.124 |
| Age—donor | 0.145 | 1.018 | 0.994 | 1.042 |
| S-Cr at RB | 0.189 | 1.001 | 1.000 | 1.002 |
| PRA max | 0.220 | 0.992 | 0.979 | 1.005 |
| EU native kidney | 0.471 | 0.777 | 0.390 | 1.545 |
| Mismatch | 0.551 | 1.078 | 0.842 | 1.381 |
| CIT hours | 0.626 | 1.009 | 0.973 | 1.047 |
| Gender—recipient, male | 0.686 | 1.145 | 0.593 | 2.212 |
| Dialysis (months) | 0.788 | 1.002 | 0.986 | 1.018 |
| PU at RB | 0.857 | 0.990 | 0.888 | 1.104 |
| Type of donor deceased | 0.975 | 1.009 | 0.577 | 1.764 |
reIgAN, recurrence of IgAN histologically verified; RB, renal biopsy; ESRD, end-stage renal disease; Tx, kidney transplant; EU, microscopic hematuria; PU, proteinuria; CIT, time of cold ischemia; S-Cr, the level of serum creatinine; ABMR, antibody mediated reaction; 2y, two years.
Cox regression model univariate.